Cefpiramide: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
No edit summary
Line 1: Line 1:
{{drugbox
{{drugbox
| IUPAC_name = (6''R'')-7-{[(2''R'')-2-(4-hydroxyphenyl)-2-[(6-methyl-<br>4-oxo-1''H''-pyridine-3-carbonyl)amino]acetyl]amino}-<br>3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-<br>5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
| IUPAC_name = (6''R'')-7-{[(2''R'')-2-(4-hydroxyphenyl)-2-[(6-methyl-<br>4-oxo-1''H''-pyridine-3-carbonyl)amino]acetyl]amino}-<br>3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-<br>5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
| image = Cefpiramide.svg
| image = Cefpiramide.png
| CAS_number = 70797-11-4
| CAS_number = 70797-11-4
| ATC_prefix = J01
| ATC_prefix = J01
Line 24: Line 24:
| routes_of_administration = [[Intravenous therapy|Intravenous]], [[Intramuscular injection|intramuscular]]
| routes_of_administration = [[Intravenous therapy|Intravenous]], [[Intramuscular injection|intramuscular]]
}}
}}
              __NOTOC__
{{SI}}
{{SI}}
{{CMG}}
==Overview==


'''Cefpiramide''' is a third-generation [[cephalosporin]] [[antibiotic]].


'''Cefpiramide''' is a third-generation [[cephalosporin]] [[antibiotic]].
                    ==References==
{{Reflist|2}}


==External links==
==External links==
* {{cite journal | author = Wang H, Yu Y, Xie X, Wang C, Zhang Y, Yuan Y, Zhang X, Liu J, Wang P, Chen M | title = In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China. | journal = J Infect Chemother | volume = 6 | issue = 2 | pages = 81-5 | year = 2000 | id = PMID 11810540}}
* {{cite journal | author = Wang H, Yu Y, Xie X, Wang C, Zhang Y, Yuan Y, Zhang X, Liu J, Wang P, Chen M | title = In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China. | journal = J Infect Chemother | volume = 6 | issue = 2 | pages = 81-5 | year = 2000 | id = PMID 11810540}}
* {{cite journal | author = Iakovlev V, Vishnevskiĭ V, Khlebnikov E, Khadin I, Plavlova M, Elagina L, Izotova G | title = [Cefpiramide (Tamicin) in the treatment of purulent complications of abdominal surgery] | journal = Antibiot Khimioter | volume = 40 | issue = 9 | pages = 30-4 | year = 1995 | id = PMID 8651827}}
* {{cite journal | author = Iakovlev V, Vishnevskiĭ V, Khlebnikov E, Khadin I, Plavlova M, Elagina L, Izotova G | title = [Cefpiramide (Tamicin) in the treatment of purulent complications of abdominal surgery] | journal = Antibiot Khimioter | volume = 40 | issue = 9 | pages = 30-4 | year = 1995 | id = PMID 8651827}}
Line 36: Line 43:
{{CephalosporinAntiBiotics}}
{{CephalosporinAntiBiotics}}


[[th:เซฟพิราไมด์]]
[[Category:Drug]]
[[Category:Cephalosporin antibiotics]]
[[Category:Cephalosporin antibiotics]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WS}}
{{WS}}

Revision as of 19:22, 8 April 2015

Cefpiramide
Clinical data
Routes of
administration		Intravenous, intramuscular
ATC code
Pharmacokinetic data
Protein binding93% to 99.3%
Elimination half-life4.44 hours
ExcretionRenal and fecal
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC25H24N8O7S2
Molar mass612.64 g/mol


WikiDoc Resources for Cefpiramide

Articles

Most recent articles on Cefpiramide

Most cited articles on Cefpiramide

Review articles on Cefpiramide

Articles on Cefpiramide in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cefpiramide

Images of Cefpiramide

Photos of Cefpiramide

Podcasts & MP3s on Cefpiramide

Videos on Cefpiramide

Evidence Based Medicine

Cochrane Collaboration on Cefpiramide

Bandolier on Cefpiramide

TRIP on Cefpiramide

Clinical Trials

Ongoing Trials on Cefpiramide at Clinical Trials.gov

Trial results on Cefpiramide

Clinical Trials on Cefpiramide at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cefpiramide

NICE Guidance on Cefpiramide

NHS PRODIGY Guidance

FDA on Cefpiramide

CDC on Cefpiramide

Books

Books on Cefpiramide

News

Cefpiramide in the news

Be alerted to news on Cefpiramide

News trends on Cefpiramide

Commentary

Blogs on Cefpiramide

Definitions

Definitions of Cefpiramide

Patient Resources / Community

Patient resources on Cefpiramide

Discussion groups on Cefpiramide

Patient Handouts on Cefpiramide

Directions to Hospitals Treating Cefpiramide

Risk calculators and risk factors for Cefpiramide

Healthcare Provider Resources

Symptoms of Cefpiramide

Causes & Risk Factors for Cefpiramide

Diagnostic studies for Cefpiramide

Treatment of Cefpiramide

Continuing Medical Education (CME)

CME Programs on Cefpiramide

International

Cefpiramide en Espanol

Cefpiramide en Francais

Business

Cefpiramide in the Marketplace

Patents on Cefpiramide

Experimental / Informatics

List of terms related to Cefpiramide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cefpiramide is a third-generation cephalosporin antibiotic. 

                    ==References==

External links

  • Wang H, Yu Y, Xie X, Wang C, Zhang Y, Yuan Y, Zhang X, Liu J, Wang P, Chen M (2000). "In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China". J Infect Chemother. 6 (2): 81–5. PMID 11810540.
  • Iakovlev V, Vishnevskiĭ V, Khlebnikov E, Khadin I, Plavlova M, Elagina L, Izotova G (1995). "[Cefpiramide (Tamicin) in the treatment of purulent complications of abdominal surgery]". Antibiot Khimioter. 40 (9): 30–4. PMID 8651827.
  • Sampi K, Hattori M (1992). "[Comparative study of cefpiramide + amikacin versus piperacillin + amikacin in granulocytopenic patients: a randomized, prospective study]". Gan To Kagaku Ryoho. 19 (9): 1315–20. PMID 1503486.


Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Cefpiramide&oldid=1085009"